Literature DB >> 688174

Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.

R C Young, G P Canellos, B A Chabner, S M Hubbard, V T DeVita.   

Abstract

One hundred sixty-one patients with advanced Hodgkin's disease achieved complete remission after combination chemotherapy. Of these, 52 (32%) have subsequently relapsed and the patterns of relapse have been studied. The probability of relapse increases with increasing stage and particularly with the presence of systemic symptoms. Patients with Nodular Sclerosis histology are more likely to relapse than those with other histologies. Patients relapse primarily (92%) in sites of previous disease and particularly in nodal sites (75%). Nodal sites most frequently involved at relapse are the central nodal areas and the left supraclavicular area. When patients relapse in new sites they tend to be either adjacent to sites of previous disease which relapse or to be contiguous with previously involved sites of disease. In the small number of patients who received prophylactic radiation therapy to sites of nodal disease after complete remission, the pattern of relapse was not significantly altered.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 688174     DOI: 10.1002/1097-0142(197808)42:2+<1001::aid-cncr2820420723>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

Authors:  Joachim Yahalom
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 2.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

3.  Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.

Authors:  M Monconduit; H Tilly; J F Menard; R Le Fur; A Barbot; H Piguet
Journal:  Blut       Date:  1987-03

4.  The case for combined-modality therapy for limited-stage Hodgkin's disease.

Authors:  Christine E Hill-Kayser; John P Plastaras; Zelig Tochner; Eli Glatstein
Journal:  Oncologist       Date:  2012-07-17

Review 5.  Current management of Hodgkin's disease.

Authors:  B C Behrens; R C Young; V T DeVita
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

6.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

7.  Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era.

Authors:  Carminia Lapuz; Anoop K Enjeti; Peter C O'Brien; Anne L Capp; Elizabeth G Holliday; Sanjiv A Gupta
Journal:  Blood Lymphat Cancer       Date:  2018-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.